CDSE1 anticorps (AA 167-372)
Aperçu rapide pour CDSE1 anticorps (AA 167-372) (ABIN1886099)
Antigène
Voir toutes CDSE1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 167-372
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 167 and 372 of CSDE1
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.250
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 20 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- CDSE1 (Cold Shock Domain Containing E1, RNA-Binding (CDSE1))
-
Autre désignation
- CSDE1
-
Sujet
-
RNA-binding protein.Required for internal initiation of translation of human rhinovirus RNA.May be involved in translationally coupled mRNA turnover.Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain.
-
Poids moléculaire
- 86 kDa
-
ID gène
- 7812
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-